Figure 7.
CBX6 directly downregulates the expression of Bone Marrow Stromal cell antigen 2 (BST2). (A) CBX6 downregulates BST2 expression in MCF-7 cells. Left: qRT-PCR analysis of BST2 mRNA in the control (empty vector) and CBX6-overexpressing (CBX6-OE) cells using GAPDH for normalization. Data are presented as means ± S.D. from three independent experiments performed in triplicate. *P < 0.05. Right: Western blot analysis of BST2 in control (empty vector) and CBX6-overexpressing cells (CBX6-OE) using GAPDH as a loading control. (B) CBX6 downregulates BST2 expression in U251MG cells. qRT-PCR analysis of BST2 mRNA levels in control (empty vector) and CBX6-overexpressing cells using GAPDH for normalization. Data are presented as means ± S.D. from three independent experiments performed in triplicate. *P < 0.05. (C) Enrichment of CBX6 and H3K27me3 at the BST2 promoter detected via ChIP-qPCR. Top: The locations of primers at the BST2 promoter. Bottom: Enrichment of CBX6 and H3K27me3 at the BST2 promoter in control (empty vector) and CBX6-overexpressing cells. Data are presented as a percentage of the input, and as means ± S.D. from three independent experiments performed in triplicate. *P < 0.05. (D) Spearman’s rank correlation coefficient indicating a negative correlation between CBX6 and BST2 mRNA levels in breast cancer tissues based on The Cancer Genome Atlas (TCGA) RNA-Seq data.